Cargando…
LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors
Autores principales: | Nosrati, A., Torpey, M.E., Ball, G.D., Shokrian, N., Campton, K.L., Cohen, S.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296919/ http://dx.doi.org/10.1016/j.jid.2022.05.941 |
Ejemplares similares
-
LB926 COVID-19 vaccine hesitancy in a cohort of hidradenitis suppurativa patients
por: Torpey, M., et al.
Publicado: (2022) -
270 Impact of COVID-19 infection on hidradenitis suppurativa activity
por: Torpey, M.E., et al.
Publicado: (2022) -
TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019) -
Acute Erythroderma in a Patient Receiving TNF-α-Blocking Therapy for Hidradenitis Suppurativa
por: Benhadou, Farida, et al.
Publicado: (2018) -
Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors
por: Oba, Muazzez Cigdem, et al.
Publicado: (2023)